Search
for
Sort by
Research 661–690 of 1000+
- Application of Platelet-Rich Plasma as a Stem Cell Treatment - anAttempt to Clarify a Common Public Misconception
- The significance of coronavirus infection in the development of reproductive and lower urinary tract lesions
- Monoclonal Antibody Against Prolactin Receptor: A Randomized Placebo-Controlled Study Evaluating Safety, Tolerability, and Pharmacokinetics of Repeated Subcutaneous Administrations in Postmenopausal Women
- Evaluation of Animal Models Suitable for Hair Research and Regeneration
- Clomiphene Citrate versus Letrozole for Ovulation Induction in PCOS: A Comparative Study
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient
- Study of Cutaneous Manifestations of Polycystic Ovarian Syndrome
- Surprisingly low infertility rate in married type 2 diabetic women: A rather curious paradox to the current opinion of insulin resistance as the joint pathogenesis of poly cystic ovary syndrome and type 2 diabetes mellitus
- Hairless or fertile? Finasteride leads to epididymal changes and infertility in rats
- Hyperandrogenism in Women: Polycystic Ovary Syndrome
- Diagnosis and treatments of hirsutism: where are we?
- Polycystic ovary syndrome: a psychosocial approach.
- Hair aging and anti-aging
- Menopause
- A Practitioner's Guide to Hair Loss Part 1—History, Biology, Genetics, Prevention, Conventional Treatments, and Herbals
- Clinical use of 5α-reductase inhibitors
- Is 3α, 17β-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
- Reversal of andro-genetic alopecia in a male. A spironolactone effect?
- Urinary 5-ene-steroid excretion in non-classical congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency (NC-3BHSD)
- Connection between granulosa cell pyroptosis and oocyte endoplasmic reticulum stress in a mouse model of polycystic ovary syndrome
- Role of Sodium–Glucose Cotransporter-2 Inhibitors in Managing Polycystic Ovary Syndrome: A Systematic Review
- POLYCYSTIC OVARY SYNDROME: DIVERSE CLINICAL PRESENTATIONS ACROSS ADOLESCENCE, REPRODUCTIVE AGE, AND MENOPAUSE
- Maternal androgen excess inhibits fetal cardiomyocytes proliferation through RB-mediated cell cycle arrest and induces cardiac hypertrophy in adulthood
- Obesity and hyperandrogenism are implicated with anxiety, depression and food cravings in women with polycystic ovary syndrome.
- Analysis of blood parameters and clinical features in women with pilonidal sinus disease: Is there a link between the disease and polycystic ovary syndrome?
- Evaluation of Sleep Quality, Restless Legs Syndrome, Anxiety and Depression in Polycystic Ovary Syndrome
- An Uncontrolled Case Series Using a Botanically Derived, β-Cyclodextrin Inclusion Complex in Two Androgenetic Alopecia-Affected Male Subjects
- Polyzystisches Ovar-Syndrom (PCOS)
- Effective treatment of skin and metabolic manifestations of hyperandrogenism: a comprehensive improvement of quality of life
- Assisted reproductive outcomes in women with different polycystic ovary syndrome phenotypes